Friday, July 10, 2026

Drug profile · INN

baloxavir

baloxavir is a polymerase acidic protein inhibitor.

NMPA: clinical trials
Patents linked 0
Pipeline programs 2
News articles 0
Drug details — baloxavir
Class
Route
Patents
0
Programs
2
Data quality
0.70

Quick answer

baloxavir is a polymerase acidic protein inhibitor.

Key facts

INN baloxavir
Mechanism Polymerase acidic protein inhibitor
Target Polymerase acidic protein

Mechanism of action

Polymerase acidic protein inhibitor

Primary target: Polymerase acidic protein

Approval history

Authority Status Date
NMPA clinical trials

Pipeline programs

  1. Baloxavir Marboxil Phase 3 · HOFFMANN-LA ROCHE · Influenza
  2. NCT02735707 Phase 3 · Disc Medicine · Respiratory tract infection

Related & competitor drugs

  1. baloxavir marboxil Polymerase acidic protein inhibitor

Frequently asked questions

What is baloxavir?

baloxavir is a polymerase acidic protein inhibitor.